All lobbying filings

Cavarocchi Ruscio Dennis Associates, L.L.C.

Cavarocchi Ruscio Dennis Associates, L.L.C. filed a Q2 report for Hereditary Hemorrhagic Telangiectasia Foundation on July 17, 2026, reporting $10,000 in lobbying income.

Lobbying for Hereditary Hemorrhagic Telangiectasia Foundation · patient advocacy organization for individuals suffering from a rare disease

As filed: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION.

All filings by Cavarocchi Ruscio Dennis Associates, L.L.C. · Everything Hereditary Hemorrhagic Telangiectasia Foundation has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

H.R. 9495/S Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT)

Health Issues

H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R. 9260/S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program

Bills named in this filing 2

H.R. 9495
Department of Defense Appropriations Act, 2027
H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.